Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Vibe coding is a fast-growing way to build software with AI by describing what you want, ...

Productivity programme likely to mean layoffs Velo gains market share from Zyn and On! in US Revenue from newer products grows by double-digits in H2 BAT's Vuse vape sees improved uptake despite ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. British American Tobacco said it was pursuing “productivity initiatives” that could lead to job cuts, as it ...

Tools such as Cursor can go a long way toward simplifying code setup. There's still a lot of work to refine the results. Conceiving an app's goals and how to get there is the hidden gotcha of AI ...

Building a full-stack application with one of the best vibe coding platforms can be as easy as describing what you are trying to build to a friend. Simply explain what you are trying to create using ...